GlassScriptPhysician profile
Matthew Hensler
NPI 1235455833
$5,112.21
in general payments reported to CMS, 2019-2025
10 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $209 · 2021: $335 · 2022: $149 · 2023: $521 · 2024: $921 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Travel and Lodging: $913 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,131.65 |
| Travel and Lodging | $912.94 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,603.38 | 2019-2025 | Inspire |
| Genzyme Corporation | $394.85 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $341.69 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $296.83 | 2024-2025 | Nucala |
| Aerin Medical INC. | $187.31 | 2019 | |
| Intersect Ent, INC. | $87.84 | 2019 | |
| Optinose US, INC. | $85.99 | 2020-2021 | |
| Stryker Corporation | $56.98 | 2019-2025 | Hemopore |
| Acclarent, INC | $43.23 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hensler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.